IGC Pharma
IGC
#10740
Rank
HK$0.16 B
Marketcap
HK$1.38
Share price
-4.61%
Change (1 day)
-47.75%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

EPS for IGC Pharma (IGC)

EPS in 2026 (TTM): -HK$0.70

According to IGC Pharma's latest financial reports the company's current EPS (TTM) is -HK$0.71. In 2025 the company made an earnings per share (EPS) of -HK$0.71 an increase over its 2024 EPS that were of -HK$1.73.

EPS history for IGC Pharma from 2006 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$0.70-0.19%
2025-HK$0.71-59.09%
2024-HK$1.73-0%
2023-HK$1.73-26.67%
2022-HK$2.3542.86%
2021-HK$1.6510.53%
2020-HK$1.4946.15%
2019-HK$1.02116.67%
2018-HK$0.47-14.29%
2017-HK$0.55-58.82%
2016-HK$1.33-45.16%
2015-HK$2.43-16.22%
2014-HK$2.9015.62%
2013-HK$2.51-87.97%
2012-HK$20.87-80.15%
2011-HK$105.12219.05%
2010-HK$32.95740%
2009-HK$3.92-91.8%
2008-HK$47.85-654.55%
2007HK$8.63-178.57%
2006-HK$10.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sterling Infrastructure
STRL
HK$141.84-20,188.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
HK$32.09-4,644.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-HK$47.54 6,633.33%๐Ÿ‡บ๐Ÿ‡ธ USA